Download PDF
Thromb Haemost 2006; 95(02): 393-395
DOI: 10.1055/s-0037-1612652
Letters to the Editor
Schattauer GmbH

The association of complement C3 genotype with coronary artery disease, markers of the metabolic syndrome and C3 plasma levels

Ramzi A. Ajjan
1   Academic Unit of Molecular Vascular Medicine, Leeds Institute of Genetics Health and Therapeutics, Faculty of Medicine and Health, University of Leeds, United Kingdom
,
Peter J. Grant
1   Academic Unit of Molecular Vascular Medicine, Leeds Institute of Genetics Health and Therapeutics, Faculty of Medicine and Health, University of Leeds, United Kingdom
,
Timothy S. Futers
1   Academic Unit of Molecular Vascular Medicine, Leeds Institute of Genetics Health and Therapeutics, Faculty of Medicine and Health, University of Leeds, United Kingdom
,
Jane M. Brown
1   Academic Unit of Molecular Vascular Medicine, Leeds Institute of Genetics Health and Therapeutics, Faculty of Medicine and Health, University of Leeds, United Kingdom
,
Angela M. Carter
1   Academic Unit of Molecular Vascular Medicine, Leeds Institute of Genetics Health and Therapeutics, Faculty of Medicine and Health, University of Leeds, United Kingdom
› Author AffiliationsFinancial support: R. Ajjan is funded by a Clinician Scientist Award from the Department of Health, UK.
Further Information

Publication History

Received 07 September 2005

Accepted after revision 20 December 2005

Publication Date:
11 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Hansson GK, Libby P, Schonbeck U. et al. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002; 91: 281-91.
    CrossrefPubMedSearch in Google Scholar
  • 2 Muscari A, Bozzoli C, Puddu GM. et al. Association of serum C3 levels with the risk of myocardial infarction. Am J Med 1995; 98: 357-64.
    CrossrefPubMedSearch in Google Scholar
  • 3 Ajjan RA, Grant PG, Futers TS. et al. Complement C3 and C-reactive protein levels in patients with stable coronary artery disease. Thromb Haemost 2005; 94: 1048-53.
    Thieme ConnectPubMedSearch in Google Scholar
  • 4 Botto M, Fong KY, So AK. et al. Molecular basis of polymorphisms of human complement component C3. J Exp Med 1990; 172: 1011-7.
    CrossrefPubMedSearch in Google Scholar
  • 5 Csaszar A, Duba J, Melegh B. et al. Increased frequency of the C3*F allele and the Leiden mutation of coagulation factor V in patients with severe coronary heart disease who survived myocardial infarction. Exp Clin Immunogenet 2001; 18: 206-12.
    CrossrefPubMedSearch in Google Scholar
  • 6 Kristensen BO, Petersen GB. Association between coronary heart disease and the C3F-gene in essential hypertension. Circulation 1978; 58: 622-5.
    CrossrefPubMedSearch in Google Scholar
  • 7 Krantz S, Stelter F, Lober M. et al. Complement component 3 (C3) genetics and diabetes mellitus. Biomed Biochim Acta 1990; 49: 1237-41.
    PubMedSearch in Google Scholar
  • 8 Szeplaki G, Prohaszka Z, Duba J. et al. Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women. Atherosclerosis 2004; 177: 383-9.
    CrossrefPubMedSearch in Google Scholar
  • 9 Muscari A, Massarelli G, Bastagli L. et al. Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men. Eur Heart J 2000; 21: 1081-90.
    CrossrefPubMedSearch in Google Scholar